G108R (p.Gly108Arg) variant of KRT5 (Keratin, type II cytoskeletal 5)

G108R (p.Gly108Arg) in KRT5 (Keratin, type II cytoskeletal 5) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.57 / 1. The record also includes population frequency data and structural context.

G108R (p.Gly108Arg) variant details